Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: The multiparametric approach is not convincing

Semin Oncol. 2017 Apr;44(2):159-160. doi: 10.1053/j.seminoncol.2017.06.001. Epub 2017 Jul 4.

¹ Oncopharmacology laboratory, Centre Antoine Lacassagne, Nice, France. Electronic address: marie-christine.etienne@nice.unicancer.fr.
² Biochemistry laboratory, CHU Tours-Bretonneau, Tours, France.
³ Biochemistry laboratory, CHU Nîmes-Carémeau, Nîmes, France.
⁴ Laboratoire de Biologie Médicale Oncologique, Institut Claudius-Regaud, CRCT, Toulouse, France.
⁵ Biochemistry Department, Hopital Européen Georges Pompidou, Paris, France.
⁶ Department of Clinical Pharmacy, SIPAM, Institut de Cancérologie Gustave Roussy, Villejuif, France.
⁷ Department of Clinical Pharmacology, CHU Jean Minjoz, Besançon, France.
⁸ SMARTc, Department of Pharmacokinetics, CHU Timone, Marseille, France.

No abstract available

Publication types